Skip to main content

March 2024

pharma courses

Applications are invited for post of Dispenser at District Health Society

Applications from eligible persons to work on contract basis for the following purely temporary posts under various schemes implemented in District Siddha Hospital, National Programme for Health Care of Elderly, Makkalai Thedi Maruthuvam, Labour Medical Health units, National Programme for Prevention and Control of Deafness (NPPCD), Health Sub-Centres, Urban Health and Wellness Centres and Primary Health Centres through District Health Society, Coimbatore.

Post : Dispenser

Vacancy for Pharmacist at District Health Society

Applications are invited for the following vacant post in Tiruvannamalai District under the National Welfare Group Scheme to work on contract basis.

Post : RBSK Pharmacist

Admission to Ph.D and M.S Programme at Indian Institute of Technology Madras

The Indian Institute of Technology Madras (IITM) is established as an autonomous institute of national importance in 1959 by the Government of India with an initial technical and financial support from Germany. IIT Madras with a number of well equipped laboratories, advanced research facilities, sophisticated services and computing & networking capabilities, is recognized to have done exceedingly well in the fields of higher technical education, research and industrial consultancy.

Interview for Pharmacist at HLL Lifecare Limited

HLL Lifecare Limited (HLL), a Schedule B, Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare is India’s leading manufacturers and marketers of Contraceptives, Healthcare and Pharma products & services.

Post : Pharmacist

TCS Hiring Pharmacovigilance Executive

Tata Consultancy Services is an Indian multinational information technology services and consulting company headquartered in Mumbai. It is a part of the Tata Group and operates in 149 locations across 46 countries.

Post : Pharmacovigilance Executive

Multiple Openings at Centre for Cellular and Molecular Biology

CSIR-Centre for Cellular and Molecular Biology, Hyderabad (CSIR-CCMB) is a premier Research Institute under the aegis of Council of Scientific & Industrial Research (CSIR), an autonomous body under the Ministry of Science & Technology, Government of India. It is a leading research organization in frontier areas of modern biology and involved in conducting high quality basic research and training in multidisciplinary areas of modern biology and to seeking potential applications of the work.

Walk In Drive for M.Pharm, B.Pharm, M.Sc Female Candidates in QA, QC, Microbiology at Alembic Pharma

Alembic Pharmaceuticals Limited is looking for female quality professionals for its API and Formulation sites near Vadodara to enrich further the 2024 International Women's Day theme of Invest in Women: Accelerate progress.

Walk-In Interview (Exclusively for Female Candidates)

Strides Pharma Hiring B.Pharm, M.Pharm in IPQA, QMS, AQA

Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging Markets. Strides has a global manufacturing footprint with eight manufacturing facilities spread across four continents, including five US FDA approved facilities and two facilities for the rest of world markets. The Company has a dedicated R&D facility in India with global filing capabilities and a strong footprint across 100 countries.

Mankind Pharma Hiring Sr Executive / Assistant Manager

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Post : Sr Executive / Assistant Manager

FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone events in cancer

FDA approved Jubbonti (denosumab-bbdz) injection as an interchangeable biosimilar to U.S.-licensed Prolia (denosumab), and Wyost (denosumab-bbdz) injection as an interchangeable biosimilar to U.S.-licensed Xgeva (denosumab).